CHIRON GAINING 350-PERSON CIBA CORNING SALES FORCE FOR LAUNCH OF bDNA PROBES
This article was originally published in The Gray Sheet
Executive Summary
CHIRON GAINING 350-PERSON CIBA CORNING SALES FORCE FOR LAUNCH OF bDNA PROBES under development by Chiron. Chiron's acquisition of Ciba Corning Diagnostics (CCD), which will be effected as part of an agreement that will give Ciba-Geigy a 49.9% stake in Chiron, will provide Chiron with an established sales group and customer and distribution base for the commercial introduction of its Quantiplex branched DNA (bDNA) signal amplification technology diagnostics. CCD, which had sales of about $98 mil. in 1993, supplements its sales organization with a 300-person service group.